Columbia Partners Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-2,774
Closed -$422K 301
2016
Q2
$422K Buy
2,774
+72
+3% +$11.2K 0.03% 331
2016
Q1
$405K Buy
2,702
+162
+6% +$24.1K 0.03% 323
2015
Q4
$412K Buy
+2,540
New +$399K 0.03% 327
2015
Q3
Sell
-3,129
Closed -$480K 336
2015
Q2
$480K Sell
3,129
-10,451
-77% -$1.67M 0.03% 260
2015
Q1
$2.17M Sell
13,580
-14,234
-51% -$2.24M 0.12% 192
2014
Q4
$4.43M Sell
27,814
-7,015
-20% -$1.09M 0.23% 135
2014
Q3
$4.89M Sell
34,829
-1,914
-5% -$250K 0.25% 135
2014
Q2
$4.35M Buy
36,743
+15,279
+71% +$1.77M 0.2% 153
2014
Q1
$2.65M Buy
21,464
+6,462
+43% +$784K 0.12% 195
2013
Q4
$1.71M Buy
15,002
+4,072
+37% +$463K 0.07% 211
2013
Q3
$1.22M Sell
10,930
-7,272
-40% -$789K 0.05% 232
2013
Q2
$1.79M Buy
+18,202
New +$1.89M 0.08% 218

Other funds holding AMGN

Columbia Partners Investment Management's AMGN Position: Q3 2016 in Review

Columbia Partners Investment Management sold out of Amgen (AMGN) in Q3 2016, closing a stake of 2,774 shares — an estimated $422K sold.

Columbia Partners Investment Management first reported a position in AMGN in Q2 2013 and held it in 12 quarters. The position peaked at $4.89M in Q3 2014. 1,518 funds tracked by Wall St. Rank hold AMGN as of Q3 2016.

  • Columbia Partners Investment Management reported no remaining Amgen position as of Q3 2016 after selling out during the quarter.
  • Columbia Partners Investment Management sold 2,774 Amgen shares in Q3 2016, an estimated $422K.
  • Columbia Partners Investment Management first reported a position in Amgen in Q2 2013 and held it in 12 quarters.
  • Columbia Partners Investment Management's Amgen position peaked at $4.89M in Q3 2014.
  • 1,518 funds tracked by Wall St. Rank held Amgen as of Q3 2016.

Based on Columbia Partners Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.